Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(565/week)
Manufacturing
(380/week)
Energy
(296/week)
Technology
(385/week)
Environment
(222/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Cancer immunotherapy
Mar 02, 2020
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Mar 02, 2020
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Mar 02, 2020
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Mar 02, 2020
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Feb 28, 2020
Accidental T-cell Discovery Represents "A New Frontier" in Cancer Treatment
Feb 28, 2020
Accidental T-cell Discovery Represents "A New Frontier" in Cancer Treatment
Feb 27, 2020
Apexigen To Present At Upcoming Investor Conferences
Feb 27, 2020
Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy in Clinical Research
Feb 27, 2020
$200B+ Cancer Immunotherapy Market Opportunity Insights, 2026 - Cancer Vaccines, Monoclonal Antibodies, Trials of T-Cell Therapies, Pipeline Overview, Competitive Landscape, and More
Feb 26, 2020
iOnctura Announces First Patient Dosed in a Phase I Clinical Study of its Novel Highly Selective PI3Kd Inhibitor, IOA-244 for Solid Tumours
Feb 26, 2020
Study Shows Surprisingly Low Number of Patients Seek Trials to Treat Cancer
Feb 25, 2020
IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Randomized Trial in First Line Non-small Cell Lung Cancer
Feb 25, 2020
KAHR Medical Raises $18 Million in Private Funding Round
Feb 25, 2020
Mirati Therapeutics Reports Year-End 2019 Financial Results And Recent Corporate Updates
Feb 24, 2020
U.S. FDA accepts GSK's sNDA application for Zejula (niraparib) for first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
Feb 20, 2020
Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial
Feb 20, 2020
Compugen Announces Phase 1/2 Triple Combination Study to Evaluate COM701 in Combination With Bristol-Myers Squibb's Opdivo® (Nivolumab) and TIGIT Inhibitor
Feb 20, 2020
Compugen Reports Fourth Quarter and Full Year 2019 Results
Feb 20, 2020
Biocare Medical Launches 7 Novel IVD Antibodies for Clinical Diagnostic and Cancer Research Applications with a Focus on Immuno-Oncology
Feb 20, 2020
Agenus Announces Positive Interim Data from Balstilimab and Zalifrelimab Clinical Trials in Second-Line Cervical Cancer
‹‹
Page 9
››
Latest News
Apr 23, 2024
Shippeo Spring Platform Release Reveals All-new Parcel Tracking, Advanced Carbon Emissions Monitoring...
Apr 23, 2024
LaPhair Capital Partners Acquires Kinexx Modular Construction to Accelerate Homeownership in Urban Communities
Apr 23, 2024
Edge Impulse Brings Industrial Computer Vision Breakthroughs in Anomaly Detection to Any Edge Device for the...
Apr 23, 2024
Faraday Future Announces Werner Wilhelm as Executive Launch Director
Apr 23, 2024
Nidec Announces Financial Results for Fiscal Year Ended March 31, 2024
Apr 23, 2024
Popular uMhlanga Rocks Whalebone Pier in South Africa Gets a New Lease on Life with Penetron Technology
Apr 23, 2024
EverGen Infrastructure Reports Q4 & Year End 2023 Results
Apr 23, 2024
Grupo Aeroportuario del Pacifico Announces Results for the First Quarter of 2024
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events